83 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
, that are necessary for the marketing and sale of the Product in such country, including Pricing Approvals and Reimbursement Approvals in such country.
“MHRA” means … those warnings or mailings described by Applicable Law.
“Reimbursement Approval” shall mean with respect to a country of the Territory which competent
8-K
EX-4.1
FENC
Fennec Pharmaceuticals Inc
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
of business), (C) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all
8-K/A
EX-10.1
17yygv5bb72h7
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-10.1
07ein
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-4.1
kwa v61b4k
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
EX-4.1
pjld rej64ldcs
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am
8-K
EX-10.1
mbeaqf 5e
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm